All In Biotech

Drug Trial Radar · NCT01150331

Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus

Efficiency of Levetiracetam Intravenous in Association With Clonazepam Versus Clonazepam Alone in Prehospital Care of Generalised Tonicoclonic Status Epilepticus

Last checked: Nov 20, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 203 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

203

Actual

Start

Jul 2009

Primary completion

May 2013

Study completion Oct 2013

Sponsor

Lead sponsor
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
URC-CIC Paris Descartes Necker Cochin
First posted
Jun 24, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Compare the efficiency of the association, first line, the intravenous levetiracetam and the intravenous clonazepam, in that of a monotherapy of clonazepam intravenous in the pre-hospital treatment of tonicoclonic generalised status epilepticus.

Conditions

  • Status; Epilepticus, Tonic-clonic

Interventions

  • Levetiracetam/ClonazepamDrug

    Association of two anti-epileptic drugs in first line

  • Clonazepam/Placebo levetiracetam IVDrug

    Association of placebo to an active comparator (clonazepam)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient's percentage having stopped convulsing in the 15 minutes following the injection. The stop of the crisis is defined as the stop of all epileptic movements (myoclonic, clonic or tonic)Time frame: 15 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Necker Hospital

    Paris, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.